1. To review the evidence regarding the impact of calcium supplementation in adults with and without CKD.
2. To review the consequences of calcium exposure in the setting of CKD-MBD on cardiovascular disease and on survival.
3. To review the evidence supporting avoidance of calcium exposure on patient centered clinical outcomes in CKD.
10/11/2017 - 4:00pm to 5:00pm CDT
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Dr. Donald Molony